{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:12:44Z","timestamp":1791756764740,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T00:00:00Z","timestamp":1550448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","award":["MMV RD\/15\/0017"],"award-info":[{"award-number":["MMV RD\/15\/0017"]}],"id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UK Medical Research Council (MRC) Career Development","award":["MR\/M021157\/1"],"award-info":[{"award-number":["MR\/M021157\/1"]}]},{"name":"UK MRC and the UK Department for International Development. CJS"},{"DOI":"10.13039\/501100002141","name":"Public Health England","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ijpddr.2019.02.004","type":"journal-article","created":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T12:57:30Z","timestamp":1550926650000},"page":"93-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Plasmodium knowlesi exhibits distinct in vitro drug susceptibility profiles from those of Plasmodium falciparum"],"prefix":"10.1016","volume":"9","author":[{"given":"Donelly A.","family":"van Schalkwyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Davina Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.K.","family":"Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirah","family":"Amir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee L.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin J.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2019.02.004_bib1","doi-asserted-by":"crossref","first-page":"24623","DOI":"10.1038\/srep24623","article-title":"Invasion characteristics of a Plasmodium knowlesi line newly isolated from a human","volume":"6","author":"Amir","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib2","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1128\/AAC.02948-15","article-title":"Adaptation of the [3H]hypoxanthine uptake assay for in vitro-cultured Plasmodium knowlesi malaria parasites","volume":"60","author":"Arnold","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.femsle.2005.09.035","article-title":"Antimalarial drug synergism and antagonism: mechanistic and clinical significance","volume":"253","author":"Bell","year":"2005","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib4","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/AAC.48.5.1807-1810.2004","article-title":"Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy","volume":"48","author":"Bennett","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib5","doi-asserted-by":"crossref","first-page":"e1038","DOI":"10.1016\/S2214-109X(17)30333-9","article-title":"Outbreak of human malaria caused by Plasmodium simium in the Atlantic Forest in Rio de Janeiro: a molecular epidemiological investigation","volume":"5","author":"Brasil","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijpddr.2019.02.004_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1086\/524888","article-title":"Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening","volume":"46","author":"Cox-Singh","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/1475-2875-12-425","article-title":"Susceptibility of human Plasmodium knowlesi infections to anti-malarials","volume":"12","author":"Fatih","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib8","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1128\/AAC.48.11.4097-4102.2004","article-title":"Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum","volume":"48","author":"Fivelman","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib9","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/cmi.12275","article-title":"Human red blood cell-adapted Plasmodium knowlesi parasites: a new model system for malaria research","volume":"16","author":"Gruring","year":"2014","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib10","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/AAC.46.5.1510-1515.2002","article-title":"In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum","volume":"46","author":"Gupta","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib11","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/AAC.01090-09","article-title":"In vitro activity of mirincamycin(U24729A) against Plasmodium falciparum isolates from Gabon","volume":"54","author":"Held","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib12","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.chom.2012.04.015","article-title":"Selective and specific inhibition of the Plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporin","volume":"11","author":"Hoepfner","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijpddr.2019.02.004_bib13","doi-asserted-by":"crossref","first-page":"E5455","DOI":"10.1073\/pnas.1414221111","article-title":"(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium","volume":"111","author":"Jimenez-Diaz","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib14","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ebiom.2015.07.033","article-title":"Natural infection of Plasmodium brasilianum in humans: man and monkey share quartan malaria parasites in the Venezuelan Amazon","volume":"2","author":"Lalremruata","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijpddr.2019.02.004_bib15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/mmi.12765","article-title":"Diverse chemotypes disrupt ion homeostasis in the Malaria parasite","volume":"94","author":"Lehane","year":"2014","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib16","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/ncomms2612","article-title":"Expansion of host cellular niche can drive adaptation of a zoonotic malaria parasite to humans","volume":"4","author":"Lim","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1073\/pnas.1216457110","article-title":"Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes","volume":"110","author":"Moon","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib19","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1128\/AAC.00928-16","article-title":"Extensive shared chemosensitivity between malaria and babesiosis blood-stage parasites","volume":"60","author":"Paul","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib20","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1126\/science.1193225","article-title":"Spiroindolones, a potent compound class for the treatment of malaria","volume":"329","author":"Rottmann","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2019.02.004_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature21038","article-title":"Plasmodium malariae and P. ovale genomes provide insights into malaria parasite evolution","volume":"542","author":"Rutledge","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2019.02.004_bib22","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(04)15836-4","article-title":"A large focus of naturally acquired Plasmodium knowlesi infections in human beings","volume":"363","author":"Singh","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2019.02.004_bib23","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/AAC.43.5.1304","article-title":"Synergistic in vitro antimalarial activity of omeprazole and quinine","volume":"43","author":"Skinner-Adams","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib24","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening","volume":"48","author":"Smilkstein","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.chom.2012.12.006","article-title":"Na+ regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials","volume":"13","author":"Spillman","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijpddr.2019.02.004_bib26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1475-2875-13-68","article-title":"First case of a naturally acquired human infection with Plasmodium cynomolgi","volume":"13","author":"Ta","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib27","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1038\/ncomms6521","article-title":"Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum","volume":"5","author":"Vaidya","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib28","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1093\/jac\/dkx279","article-title":"Comparison of the susceptibility of Plasmodium knowlesi and Plasmodium falciparum to antimalarial agents","volume":"72","author":"van Schalkwyk","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib29","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1124\/jpet.108.141929","article-title":"The inhibitory effect of 2-halo derivatives of D-glucose on glycolysis and on the proliferation of the human malaria parasite Plasmodium falciparum","volume":"327","author":"van Schalkwyk","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib30","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/1475-2875-13-390","article-title":"Changing epidemiology of malaria in Sabah, Malaysia: increasing incidence of Plasmodium knowlesi","volume":"13","author":"William","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2019.02.004_bib31","series-title":"World Malaria Report","author":"WHO (World Health Organization)","year":"2015"},{"key":"10.1016\/j.ijpddr.2019.02.004_bib32","series-title":"Guidelines for the Treatment of Malaria","author":"WHO (World Health Organization)","year":"2015"},{"key":"10.1016\/j.ijpddr.2019.02.004_bib33","series-title":"World Malaria Report","author":"WHO (World Health Organization)","year":"2018"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320718301866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320718301866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:47:50Z","timestamp":1761922070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320718301866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":33,"alternative-id":["S2211320718301866"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2019.02.004","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasmodium knowlesi exhibits distinct in vitro drug susceptibility profiles from those of Plasmodium falciparum","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2019.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}